Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Nature Medicine|July 15, 2003
Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia AIngrid Hrachovinová, Beatrice Cambien, Ali Hafezi-Moghadam, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 1, 1990
1,4-Dihydronaphthoquinones as water-soluble inhibitors of 5-lipoxygenaseR G Schaub, A Yamashita, M K Bach, et al.
Thrombosis and Haemostasis|April 20, 2001
Intratracheal administration of recombinant human factor IX (BeneFix) achieves therapeutic levels in hemophilia B dogsK E Russell, M S Read, D A Bellinger, et al.
Circulation|November 21, 2007
First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteersJames C Gilbert, Tia DeFeo-Fraulini, Renta M Hutabarat, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 28, 2012
ARC15105 is a potent antagonist of von Willebrand factor mediated platelet activation and adhesionJolanta M Siller-Matula, Yahye Merhi, Jean-François Tanguay, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2012
Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasmaM E Gorczyca, S C Nair, B Jilma, et al.
Journal of Vascular Surgery|November 8, 2002
P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat modelDaniel D Myers, Peter K Henke, Shirley K Wrobleski, et al.
Journal of Vascular Surgery|August 17, 2005
Decreased venous thrombosis with an oral inhibitor of P selectinDaniel D Myers, John E Rectenwald, Patricia W Bedard, et al.
Thrombosis Research|November 23, 2013
Drug-drug interaction of the anti-TFPI aptamer BAX499 and factor VIII: studies of spatial dynamics of fibrin clot formation in hemophilia ALeonid A Parunov, Natalia P Soshitova, Olga A Fadeeva, et al.
Pageof 12